Skip to main content
News and Events banner photo

News & Events
Stay Informed with Industry Insights and Follow Our Progress

Scientist in background holding filled vial in foreground


Company News

Ractigen Therapeutics Announces the Appointment of Harri Järveläinen as Chief Operating Officer

January 9, 2023
SUZHOU, Jiangsu, China -- Ractigen Therapeutics, Inc. announced today that Dr. Harri Järveläinen has been…
Company News

Ractigen Therapeutics closes an additional $30 million in Series A+ funding to push development of its RNAa platform

January 27, 2022
Ractigen Therapeutics today announced the closing of a Series A+ financing round totaling $30 million…
Company News

Ractigen Therapeutics closes on $17 Million Series A to advance lead program into clinical phase, led by Hillhouse Venture Capital

February 10, 2021
Ractigen Therapeutics, a leading company in the saRNA drug space, announced that it has closed…
Company News

CB Insights lists Ractigen as one of the Top RNA biotech companies in China

May 19, 2020
Today, CB Insights China published, for the first time, a top list of RNA biotech…
Company News

Delegation from Nantong University Medical School visits Ractigen

July 11, 2018
Today, a 5-member delegation, led by the dean Professor Fei Sun, from Nantong University Medical…
Company News

Scientists from Ractigen and KRIBB publish new study on saRNA-guided activation of VHL gene in renal cell carcinoma

February 7, 2018
Today, an article entitled "Small activating RNA induced expression of VHL gene in renal cell…